Global Polymerase Chain Reaction Market Growth (Status and Outlook) 2023-2029

Global Polymerase Chain Reaction Market Growth (Status and Outlook) 2023-2029

Polymerase chain reaction is a laboratory technique used to copy a particular region of DNA. The main goal of PCR is to make enough copies of the targeted region of DNA so that the copies can be used for analysis. There are five core ingredients required to set up PCR namely DNA template, primers, DNA nucleotides, Taq polymerase, and buffer. PCR is very precise technique and can be used to amplify a specific short DNA strand in a mixture of DNA molecules. Before PCR, the DNA segments were amplified by using vectors in bacteria. This process took weeks to get the amplified DNA. As PCR is faster than this technique, PCR was readily accepted on the global level. PCR is also more efficient than the conventional techniques used for amplification. 

LPI (LP Information)' newest research report, the “Polymerase Chain Reaction Industry Forecast” looks at past sales and reviews total world Polymerase Chain Reaction sales in 2022, providing a comprehensive analysis by region and market sector of projected Polymerase Chain Reaction sales for 2023 through 2029. With Polymerase Chain Reaction sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymerase Chain Reaction industry.

This Insight Report provides a comprehensive analysis of the global Polymerase Chain Reaction landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polymerase Chain Reaction portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polymerase Chain Reaction market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymerase Chain Reaction and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymerase Chain Reaction.

The global Polymerase Chain Reaction market size is projected to grow from US$ 6293.9 million in 2022 to US$ 8967 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.

The advancement in the technology of qPCR and dPCR leading to automation, improved accuracy, and enhanced sensitivity majorly drive the market growth. These products provide high level of efficiency and productivity in research and drug discovery and reduce the time required for the novel drug development. In addition, there is increased demand for polymerase chain reaction technologies owing to increase in number of hospitals and research centers. Furthermore, the increase in number of patients suffering from infectious diseases and rise in funding in gene therapy and human genome projects will also help to fuel the growth of the global polymerase chain reaction technologies market. Moreover, there is growth in demand for polymerase chain reaction technologies in the field of life science, clinical diagnostics, and others, which would further drive the market. However, growth of non-validated home brew test and unstable reimbursement policies are projected to hinder the growth of global polymerase chain reaction technologies market.

This report presents a comprehensive overview, market shares, and growth opportunities of Polymerase Chain Reaction market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Real-Time PCR
Traditional PCR
Digital PCR

Segmentation by application
Diagnostic Centers & Hospitals
Academic & Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
QIAGEN
F. Hoffmann-La Roche
Thermo Fisher Scientific
bioMérieux

Please note: The report will take approximately 2 business days to prepare and deliver.